MedPath

the Effect of Preoperative Sodium Ibuprofen on Postoperative Endodontic Pain

Phase 1
Completed
Conditions
Irreversible Pulpitis
Interventions
Drug: nurofen
Registration Number
NCT04964622
Lead Sponsor
Cairo University
Brief Summary

The aim of this study is to clinically compare post-operative pain levels after administration of preoperative single dose of sodium ibuprofen versus placebo for patient with symptomatic irreversible pulpitis related to mandibular molar teeth.

Detailed Description

Oral pharmacologic agents have been the primary option, and the use of drugs has increased exponentially. Many pharmacological agents have been used to manage endodontic pain, including Non-steroidal Anti-inflammatory Drugs (NSAIDs),.administration of NSAIDs before root canal treatment will reduce inflammatory process before it begins. NSAIDs are widely used to control post endodontic pain They act by blocking the activity of cyclooxygenase (COX 1 and 2) enzyme. In human dental pulps with irreversible pulpitis, a higher level of expression of COX 2.In cases of irreversible pulpitis NSAIDS can be administered preoperatively since they reduce the level of prostaglandinE2(PGE2) which is responsible for sensitization of nociceptors. Ibuprofen is one of the most commonly used NSAIDs and a potent inhibitor of prostaglandin (PG) synthesis that can manage various pain types and has anti-inflammatory activity. Enhancements in ibuprofen acid's pharmacokinetics have led to the development of ibuprofen salts with a faster dissolution rate and onset of action. These ibuprofen salts.Fast acting ibuprofen like Sodium ibuprofen delivers maximum plasma drug concentrations at about 30-40 min, compared with around 90-120 min for standard ibuprofen acid formulations

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients above 18 years old and below 66.
  • Male or female
  • Patients seeking root canal treatment
  • Mandibular posterior molarteeth with Symptomatic irreversible pulpitis .
  • Spontaneous pain
  • Systematically healthy patient(ASA I,II)
Exclusion Criteria
  • Medically compromised patients having significant systemic disorders. (ASA III or IV)
  • History of intolerance to NSAIDS.
  • Patients with two or more adjacent teeth requiring endodontic treatment.
  • External root resorption
  • Internal root resorption
  • Vertical root fracture
  • Periapical lesion
  • Pregnancy
  • Use of ibuprofen in the last 12 hour
  • Bleeding disorder
  • Long term corticosteroid use
  • Mobility Grade II or III.
  • Pocket depth more than 5mm.
  • Previous root canal therapy.
  • Non-restorability
  • Temporomandibular joint (TMJ) problems, bruxism, clenching or traumatic occlusion.
  • Inability to perceive the given instructions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nurofennurofensodium ibuprofen 1 tablet (256) 30 minutes before treatment administered once (oral)
placebonurofenstarch tablet 30 minutes before treatment administered once (oral)
Primary Outcome Measures
NameTimeMethod
postoperative painPost-operative pain will be assessed immediately after treatment ,at 6 hours, at 12 hours, at 24 hours and 48 hours

pain will be measured by visual analogue scale(VAS). Postoperative pain levels were documented by the patients immediately after obturation, 6, 12, 24 and 48 hours post-treatment. The VAS consists a 10-cm line anchored by 2 extremes, ''no pain'' and ''pain as bad as it could be.'' Patients were asked to make a mark on the line that represents their level of perceived pain. Readings were transformed into categories; no pain (range of 0-4mm), mild pain (range of 5-44mm), moderate pain (range of 45-74mm) and severe pain (range of 75-100mm)

Secondary Outcome Measures
NameTimeMethod
need for rescue medicationAmount of analgesics taken by the patient after root canal treatment, up to 48 hours postoperatively

Amount of analgesics taken by the patient after root canal treatment

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath